NDC 50090-5832-01 - Memantine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5832
- Requested NDC
- 50090-5832-01
- Package NDCs from labels
- 50090-5832-0, 50090-5832-1, 50090-5832-2, 50090-5832-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-11-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Memantine Hydrochloride - A-S Medication Solutions | A-S Medication Solutions | 2023-11-24 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5832-0 | Memantine Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 5 | |
| 50090-5832-1 | Memantine Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 5 | |
| 50090-5832-2 | Memantine Hydrochloride | 180 in 1 BOTTLE | TABLET | 180 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5832 | MEMANTINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 5 | Current NDC, Legacy NDC, 3 package rows | 20231125_66db6d61-cf1d-46ca-a645-19e9a20f4617.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5832-0 | EA - Each | 50090-5832 | faee8f23-5404-4937-9351-4f6370930389 | 1 | 2022-07-06 |
| 50090-5832-1 | EA - Each | 50090-5832 | db3dae4d-6b8b-4bb6-b529-51d4f5d574b7 | 1 | 2022-04-06 |
| 50090-5832-2 | EA - Each | 50090-5832 | a28290dd-7d11-4f82-b331-c0dd634c0863 | 1 | 2022-08-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Ajanta Pharma USA Inc. | 292671f2-f221-4a3d-a110-a266a9527e04 | 2025-11-27 | Warnings, Adverse reactions | 996561 996571 JY0WD0UA60 |
| Memantine hydrochloride | MEMANTINE HYDROCHLORIDE | Macleods Pharmaceuticals Limited | 62e32b0b-1eb2-424d-bfd2-d27ef27d35f3 | 2025-10-14 | Warnings, Adverse reactions | JY0WD0UA60 |
| Memantine and Donepezil | MEMANTINE AND DONEPEZIL | Macleods Pharmaceuticals Limited | 3d9a23dc-8cbe-47c3-a048-70d86cb9dc14 | 2025-07-10 | Warnings, Adverse reactions | JY0WD0UA60 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Carlsbad Technology, Inc. | 30b4d5c4-0a31-c385-e063-6394a90adbce | 2025-06-23 | Warnings, Adverse reactions | 996561 996571 JY0WD0UA60 |
| memantine hydrochloride and donepezil hydrochloride | MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | Vitruvias Therapeutics, Inc. | c888a2b2-92c6-46ae-99ea-21de616208b6 | 2025-06-20 | Warnings, Adverse reactions | JY0WD0UA60 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3662b11a-354a-b683-e063-6394a90a0086 | 2025-05-30 | Warnings, Adverse reactions | 996571 JY0WD0UA60 |
| Memantine Hydrochloride | MEMANTINE | Rising Pharma Holdings, Inc. | a282fbed-8304-458e-a0e9-5eaccc95339b | 2025-04-30 | Warnings, Adverse reactions | JY0WD0UA60 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Amneal Pharmaceuticals LLC | f2b7538d-8ca1-4ac7-a172-d268e2fa9a52 | 2025-04-29 | Warnings, Adverse reactions | JY0WD0UA60 |
| Memantine | MEMANTINE | American Health Packaging | 304a3059-4f7f-4ec4-839d-86492bb5e07b | 2025-04-22 | Warnings, Adverse reactions | 996561 996571 JY0WD0UA60 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 30b8b982-db74-7cf4-e063-6394a90a3a6b | 2025-03-19 | Warnings, Adverse reactions | 996561 JY0WD0UA60 |
| Memantine and Donepezil Hydrochlorides Extended-release | MEMANTINE AND DONEPEZIL | AvKARE | 2d821427-34ca-3c5d-e063-6394a90a9013 | 2025-02-06 | Warnings, Adverse reactions | JY0WD0UA60 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Coupler LLC | 2d54be77-75b2-76b3-e063-6294a90a0cc0 | 2025-02-04 | Warnings, Adverse reactions | 996571 JY0WD0UA60 |
| MEMANTINE AND DONEPEZIL HYDROCHLORIDES | MEMANTINE AND DONEPEZIL HYDROCHLORIDES | ANI Pharmaceuticals, Inc. | c42a995d-cd0f-466c-8f47-43c7f32d9675 | 2025-01-01 | Warnings, Adverse reactions | JY0WD0UA60 |
| Memantine and Donepezil Hydrochlorides Extended-release | MEMANTINE AND DONEPEZIL | Amneal Pharmaceuticals NY LLC | 2335950c-be3b-4248-ad04-e9763aee47d2 | 2024-12-17 | Warnings, Adverse reactions | JY0WD0UA60 |
| Memantine hydrochloride | MEMANTINE HYDROCHLORIDE | Zydus Lifesciences Limited | ec825bef-2313-45c2-8858-b43197680155 | 2024-11-30 | JY0WD0UA60 | |
| memantine hydrochloride | MEMANTINE HYDROCHLORIDE | A-S Medication Solutions | 4d48c958-b606-4427-8502-53450718eefb | 2024-10-21 | Warnings, Adverse reactions | 996571 JY0WD0UA60 |
| memantine hydrochloride | MEMANTINE HYDROCHLORIDE | A-S Medication Solutions | 9b4e3c54-c001-47cc-bc3a-7d4bf25ccfaf | 2024-10-21 | Warnings, Adverse reactions | 996561 JY0WD0UA60 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | A-S Medication Solutions | ca619439-f4ca-43f1-9261-9aa2b6dc7450 | 2024-09-05 | Warnings, Adverse reactions | 996561 JY0WD0UA60 |
| Memantine Hydrochloride | MEMANTINE HYDROCHLORIDE | Zydus Lifesciences Limited | 514421f3-f525-43e8-aecc-8b2bbffd00dc | 2024-08-16 | 996561 996571 JY0WD0UA60 | |
| Memantine | MEMANTINE | NCS HealthCare of KY, LLC dba Vangard Labs | a5dcc0e7-761f-4294-bb48-e5ee4a1e2f67 | 2024-08-12 | Warnings, Adverse reactions | 996561 996571 JY0WD0UA60 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.